Korean Journal of Ophthalmology10.3341/kjo.2014.28.6.4662014286466Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual AcuityYoung Suk Chang, Jung Il Han, Su Jin Yoo, Young Ju Lew, Jae Hui Kim,,
Age and Ageing10.1093/ageing/afab2622021511Ten-year mortality and long-term visual acuity outcomes in patients with exudative age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor injectionsSu Ling Young, Martin J Anderson, Shyamanga Borooah, Ana-Maria Armbrecht, Peter D Cackett,
Journal of Personalized Medicine10.3390/jpm11101024202111101024Association between Retinal Thickness Variability and Visual Acuity Outcome during Maintenance Therapy Using Intravitreal Anti-Vascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular DegenerationTimothy Y. Y. Lai, Ricky Y. K. Lai
Ophthalmologica10.1159/00044538820162354225-232Arteriosclerotic Changes after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Drugs in Patients with Exudative Age-Related Macular DegenerationTomoaki Shiba, Mao Takahashi, Izumi Yoshida, Hikari Taniguchi, Tadashi Matsumoto, Yuichi Hori,,
American Journal of Ophthalmology10.1016/j.ajo.2008.10.00820091472375-376Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular TractionGiuseppe Querques,
Journal of the Korean Ophthalmological Society10.3341/jkos.2017.58.10.1145201758101145Anatomical Characteristics of End-stage Exudative Age-related Macular Degeneration Refractory to Intravitreal Anti-vascular Endothelial Growth Factor InjectionJun Gi Hong, Young Wook Cho, Ji Hye Jang,,
Ophthalmology10.1016/j.ophtha.2010.04.01520111181101-110Effects of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Exudative Age-Related Macular DegenerationSung Jun Lee, Hyoung Jun Koh,
Investigative Opthalmology & Visual Science10.1167/iovs.15-1840420165741798Intravitreal Anti–Vascular Endothelial Growth Factor Therapy and Retinal Nerve Fiber Layer Loss in Eyes With Age-Related Macular Degeneration: A Meta-AnalysisHyun Jin Shin, Soo-Nyung Kim, Hyewon Chung, Tae-Eun Kim, Hyung Chan Kim
Ophthalmology Retina10.1016/j.oret.2020.05.00520204111047-1053Long-Term Follow-up of Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Anti–Vascular Endothelial Growth Factor InjectionsFelix F. Kung, Matthew R. Starr, Yvonne T. Bui, Camilo A. Mejia, Sophie J. Bakri,
Ophthalmology Retina10.1016/j.oret.2019.05.01720204119-30Visual Acuity Outcomes and Anti–Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration PatientsThomas A. Ciulla, Rehan M. Hussain, John S. Pollack, David F. Williams,